Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Published in: The journal of nutrition, health & aging 6/2017

01-06-2017

No associations of 25-hydroxycholecalciferol and parathyroid hormone concentrations with calcaneal bone characteristics in community-dwelling elderly subjects: A cross-sectional study

Authors: A. Jungert, Monika Neuhäuser-Berthold

Published in: The journal of nutrition, health & aging | Issue 6/2017

Login to get access

Abstract

Objective

This study examined the associations of 25-hydroxycholecalciferol [25(OH)D3] and intact parathyroid hormone (iPTH) concentrations with bone status parameters in elderly subjects.

Design/Setting

Cross-sectional data based on the follow-up 2008 of the longitudinal study on nutrition and health status of senior citizens in Giessen, Germany.

Participants

One hundred eighty-eight independently living subjects aged 66–96 years.

Measurements

Serum concentrations of 25(OH)D3, iPTH, N-terminal propeptide of type 1 collagen (P1NP) and activity of alkaline phosphatase (ALP) were assessed. Broadband ultrasound attenuation, speed of sound and stiffness index were determined by calcaneal quantitative ultrasound (QUS). Multiple linear regression analyses were performed to analyse associations of 25(OH)D3 and iPTH with bone status parameters.

Results

Median (range) 25(OH)D3 and iPTH concentrations were 62.8 (29.9–106.7) nmol/L and 4.6 (1.3–21.0) pmol/L, respectively. Neither 25(OH)D3 nor iPTH was associated with calcaneal bone characteristics measured by QUS, whereas negative associations between 25(OH)D3 and bone formation markers (P1NP and ALP) were found. In a sub analysis, 25(OH)D3 was negatively associated with ALP only in subjects with iPTH concentrations > 4.59 pmol/L.

Conclusion

The present study provides no evidence for independent associations of 25(OH)D3 and iPTH with calcaneal bone characteristics in community-dwelling elderly subjects with 25(OH)D3 concentrations between 30 and 107 nmol/L. However, 25(OH)D3 interacts with bone formation markers, particularly in subjects with high iPTH concentrations.
Literature
1.
Arabi A, Baddoura R, Awada H, Salamoun M, Ayoub G, El-Hajj Fuleihan G. Hypovitaminosis D osteopathy: is it mediated through PTH, lean mass, or is it a direct effect? Bone 2006;39: 268–75.
2.
Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int 2012;23:971–80.CrossRefPubMed
3.
Bhattoa HP, Nagy E, More C, Kappelmayer J, Balogh A, Kalina E, Antal-Szalmas P. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study. Osteoporos Int 2013;24: 179–86.CrossRefPubMed
4.
Garnero P, Munoz F, Sornay-Rendu E, Delmas PD. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone 2007;40: 716–22.CrossRefPubMed
5.
Ilich JZ, Brownbill RA, Tamborini L. Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density. Eur J Clin Nutr 2003;57: 554–65.CrossRefPubMed
6.
Kauppi M, Impivaara O, Mäki J, Heliövaara M, Marniemi J, Montonen J, Jula A. Vitamin D status and common risk factors for bone fragility as determinants of quantitative ultrasound variables in a nationally representative population sample. Bone 2009;45: 119–24.CrossRefPubMed
7.
Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 2009;94: 1244–50.CrossRefPubMed
8.
Macdonald HM, Mavroeidi A, Barr RJ, Black AJ, Fraser WD, Reid DM. Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone 2008;42: 996–1003.CrossRefPubMed
9.
Olmos JM, Hernández JL, García-Velasco P, Martínez J, Llorca J, González-Macías J. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 2016;27: 105–13.CrossRefPubMed
10.
Saquib N, von Mühlen D, Garland CF, Barrett-Connor E. Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study. Osteoporos Int 2006;17: 1734–41.CrossRefPubMed
11.
Sohl E, de Jongh RT, Swart KM, Enneman AW, van Wijngaarden JP, van Dijk SC, Ham AC, van der Zwaluw NL, Brouwer-Brolsma EM, van der Velde N, de Groot CP, te Velde SJ, Lips P, van Schoor NM. The association between vitamin D status and parameters for bone density and quality is modified by body mass index. Calcif Tissue Int 2015;96: 113–22.CrossRefPubMed
12.
van Ballegooijen AJ, Robinson-Cohen C, Katz R, Criqui M, Budoff M, Li D, Siscovick D, Hoofnagle A, Shea SJ, Burke G, de Boer IH, Kestenbaum B. Vitamin D metabolites and bone mineral density: the multi-ethnic study of atherosclerosis. Bone 2015;78: 186–93.CrossRefPubMedPubMedCentral
13.
Vanderschueren D, Pye SR, O’Neill TW, Lee DM, Jans I, Billen J, Gielen E, Laurent M, Claessens F, Adams JE, Ward KA, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Wu FC, Boonen S. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab 2013;98: 995–1005.CrossRefPubMed
14.
Zhen D, Liu L, Guan C, Zhao N, Tang X. High prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factors. Bone 2015;71: 1–6.CrossRefPubMed
15.
Zochling J, Sitoh YY, Lau TC, Cameron ID, Cumming RG, Lord SR, Schwarz J, Trube A, March LM, Sambrook PN. Quantitative ultrasound of the calcaneus and falls risk in the institutionalized elderly: sex differences and relationship to vitamin D status. Osteoporos Int 2002;13: 882–7.CrossRefPubMed
16.
Avenell A, Mak JC, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 2014;4:CD000227.
17.
Rizzoli R, Boonen S, Brandi ML, Bruyère O, Cooper C, Kanis JA, Kaufman JM, Ringe JD, Weryha G, Reginster JY. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 2013;29: 305–13.CrossRefPubMed
18.
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96: 53–8.CrossRefPubMed
19.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96: 1911–30.CrossRefPubMed
20.
21.
Blanchet C, Giguère Y, Prud’homme D, Turcot-Lemay L, Dumont M, Leduc G, Côte S, Laflamme N, Rousseau F, Dodin S. Leisure physical activity is associated with quantitative ultrasound measurements independently of bone mineral density in postmenopausal women. Calcif Tissue Int 2003;73: 339–49.CrossRefPubMed
22.
Martínez J, Olmos JM, Hernández JL, Pinedo G, Llorca J, Obregón E, Valero C, González-Macías J. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta 2009;409: 70–4.CrossRefPubMed
23.
Khosla S. Pathogenesis of age-related bone loss in humans. J Gerontol A Biol Sci Med Sci 2013;68: 1226–35.CrossRefPubMed
24.
Jungert A, Neuhäuser-Berthold M. Sex-specific determinants of serum 25-hydroxyvitamin D3 concentrations in an elderly German cohort: a cross-sectional study. Nutr Metab (Lond) 2015;12:2.CrossRef
25.
Alcaraz A, González-López R, Morote J, de la Piedra C, Meseguer C, Esteban E, Climent M, González-Gragera B, Alvarez-Ossorio JL, Chirivella I, et al. Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study. Br J Cancer 2013;109: 121–30.CrossRefPubMedPubMedCentral
26.
Dusso A, González EA, Martin KJ. Vitamin D in chronic kidney disease. Best Pract Res Clin Endocrinol Metab 2011;25: 647–55.CrossRefPubMed
27.
Vasikaran SD, Chubb SP, Ebeling PR, Jenkins N, Jones GR, Kotowicz MA, Morris HA, Schneider HG, Seibel MJ, Ward G. Harmonised Australian reference intervals for serum PINP and CTX in adults. Clin Biochem Rev 2014;35: 237–42.PubMedPubMedCentral
28.
Woitge HW, Seibel MJ, Ziegler R. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases. Clin Chem 1996;42: 1796–804.PubMed
29.
Roche Diagnostics GmbH. Elecsys 1010/2010/Modular analytics E170. Parathyroid hormone PTH, intact. Mannheim, Germany: Roche Diagnostics; 2003.
30.
Roche Diagnostics GmbH. Elecsys 1010/2010 and Modular analytics E170, Cortisol. Mannheim, Germany: Roche Diagnostics; 2005.
31.
Roche Diagnostics GmbH. Elecsys and cobas analyzer. 25-Hydroxyvitamin D3, Vitamin D3 (25-OH). Mannheim, Germany: Roche Diagnostics; 2007.
32.
Roche Diagnostics GmbH. Elecsys and cobas e analyzers. Thyrotropin, TSH. Mannheim, Germany: Roche Diagnostics; 2007.
33.
Roche Diagnostics GmbH. Elecsys and cobas e analyzers. Total procollagen type 1 amino-terminal propeptide, total P1NP. Mannheim, Germany: Roche Diagnostics; 2007.
34.
Roche Diagnostics GmbH. Roche/Hitachi. Alkalische Phosphatase flüssig nach IFCC (alkaline phosphatase), ALP. Mannheim, Germany: Roche Diagnostics; 2008.
35.
Roche Diagnostics GmbH. Elecsys 1010/2010/Modular analytics E170. Follikelstimulierendes Hormon (follicle stimulating hormone), FSH. Mannheim, Germany: Roche Diagnostics; 2004.
36.
Roche Diagnostics GmbH. Elecsys 1010/2010/Modular analytics E170. Testosterone. Mannheim, Germany: Roche Diagnostics; 2004.
37.
Roche Diagnostics GmbH. Elecsys 1010/2010 and Modular analytics E170. Estradiol -E2. Mannheim, Germany: Roche Diagnostics; 2005.
38.
Roche Diagnostics GmbH. Elecsys 1010/2010 and Modular analytics E170. Luteinizing hormone, LH. Mannheim, Germany: Roche Diagnostics; 2005.
39.
Levey AS, Greene T, Kusek J, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000;11:155A.
40.
Edelmann-Schäfer B, Berthold LD, Stracke H, Lührmann PM, Neuhäuser-Berthold M. Identifying elderly women with osteoporosis by spinal dual X-ray absorptiometry, calcaneal quantitative ultrasound and spinal quantitative computed tomography: a comparative study. Ultrasound Med Biol 2011;37: 29–36.CrossRefPubMed
41.
Njeh CF, Blake GM. Calcaneal quantitative ultrasound devices: water coupled. In: Njeh CF, Hans D, Fuerst T, Glüer CC, Genant HK, (eds). Quantitative ultrasound. Assessment of osteoporosis and bone status. London: Martin Dunitz;1999. pp. 109–24.
42.
Roubenoff R, Baumgartner RN, Harris TB, Dallal GE, Hannan MT, Economos CD, Stauber PM, Wilson PW, Kiel DP. Application of bioelectrical impedance analysis to elderly populations. J Gerontol A Biol Sci Med Sci 1997;52:M129–36.CrossRefPubMed
43.
Krems C, Lührmann PM, Neuhäuser-Berthold M. Physical activity in young and elderly subjects. J Sports Med Phys Fitness 2004;44: 71–6.PubMed
44.
Lührmann PM, Herbert BM, Gaster C, Neuhäuser-Berthold M. Validation of a self-administered 3-day estimated dietary record for use in the elderly. Eur J Nutr 1999;38: 235–40.CrossRefPubMed
45.
Michelsen J, Wallaschofski H, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, Hannemann A. Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone 2013;57: 399–404.CrossRefPubMed
46.
Lee S, Teschemaker AR, Daniel M, Maneno MK, Johnson AA, Wutoh AK, Lee E. Calcium and vitamin D use among older adults in U.S.: results from national survey. J Nutr Health Aging 2016;20: 300–5.CrossRefPubMed
47.
Trimpou P, Bosaeus I, Bengtsson BA, Landin-Wilhelmsen K. High correlation between quantitative ultrasound and DXA during 7 years of follow-up. Eur J Radiol 2010;73: 360–4.CrossRefPubMed
48.
Olmos JM, Hernández JL, Martínez J, Pariente E, Llorca J, González-Macías J. Bone turnover markers in Spanish adult men The Camargo Cohort Study. Clin Chim Acta 2010;411: 1511–5.CrossRefPubMed
Metadata
Title
No associations of 25-hydroxycholecalciferol and parathyroid hormone concentrations with calcaneal bone characteristics in community-dwelling elderly subjects: A cross-sectional study
Authors
A. Jungert
Monika Neuhäuser-Berthold
Publication date
01-06-2017
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 6/2017
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-016-0785-z

Other articles of this Issue 6/2017

The journal of nutrition, health & aging 6/2017 Go to the issue

OriginalPaper

Validation of the photography method for nutritional intake assessment in hospitalized elderly subjects

OriginalPaper

Comparison of intermittent fasting versus caloric restriction in obese subjects: A two year follow-up

OriginalPaper

Changes in nutritional and functional status in longer stay patients admitted to a geriatric evaluation and management unit

OriginalPaper

Older adults with fear of falling show deficits in motor imagery of gait

OriginalPaper

Assessing the risk of sarcopenia in the elderly: The Mini Sarcopenia Risk Assessment (MSRA) questionnaire

OriginalPaper

Does visual impairment affect social ties in late life? Findings of a multicenter prospective cohort study in Germany
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits